Dominique Bluteau
Overview
Explore the profile of Dominique Bluteau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
554
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Troadec M, Porteu F, Arcangeli M, Foudi A, Bluteau D, De Sepulveda P, et al.
Bull Cancer
. 2023 Feb;
110(3):331-335.
PMID: 36775700
This article highlights the presentations from the 2021 scientific meeting of the Club Hematopoiesis and Oncogenesis. This annual meeting focuses on hematopoiesis and oncogenic mechanisms. Various topics were presented: expansion...
2.
Sebert M, Gachet S, Leblanc T, Rousseau A, Bluteau O, Kim R, et al.
Cell Stem Cell
. 2023 Feb;
30(2):153-170.e9.
PMID: 36736290
Fanconi anemia (FA) patients experience chromosome instability, yielding hematopoietic stem/progenitor cell (HSPC) exhaustion and predisposition to poor-prognosis myeloid leukemia. Based on a longitudinal cohort of 335 patients, we performed clinical,...
3.
Glembotsky A, Sliwa D, Bluteau D, Balayn N, Oyarzun C, Raimbault A, et al.
Haematologica
. 2018 Dec;
104(6):1244-1255.
PMID: 30545930
Germline mutations lead to thrombocytopenia and platelet dysfunction in familial platelet disorder with predisposition to acute myelogenous leukemia (AML). Multiple aspects of platelet function are impaired in these patients, associated...
4.
Bogliolo M, Bluteau D, Lespinasse J, Pujol R, Vasquez N, Dubois dEnghien C, et al.
Genet Med
. 2017 Aug;
20(4):458-463.
PMID: 28837157
PurposeMutations in genes involved in Fanconi anemia (FA)/BRCA DNA repair pathway cause cancer susceptibility diseases including familial breast cancer and Fanconi anemia (FA). A single FA patient with biallelic FANCM...
5.
Bluteau D, Masliah-Planchon J, Clairmont C, Rousseau A, Ceccaldi R, Dubois dEnghien C, et al.
J Clin Invest
. 2017 Mar;
127(3):1117.
PMID: 28248207
No abstract available.
6.
Bluteau D, Masliah-Planchon J, Clairmont C, Rousseau A, Ceccaldi R, Dubois dEnghien C, et al.
J Clin Invest
. 2016 Aug;
126(9):3580-4.
PMID: 27500492
Fanconi anemia (FA) is a recessive genetic disease characterized by congenital abnormalities, chromosome instability, progressive bone marrow failure (BMF), and a strong predisposition to cancer. Twenty FA genes have been...
7.
Antony-Debre I, Manchev V, Balayn N, Bluteau D, Tomowiak C, Legrand C, et al.
Blood
. 2014 Dec;
125(6):930-40.
PMID: 25490895
To explore how RUNX1 mutations predispose to leukemia, we generated induced pluripotent stem cells (iPSCs) from 2 pedigrees with germline RUNX1 mutations. The first, carrying a missense R174Q mutation, which...
8.
Hilpert M, Legrand C, Bluteau D, Balayn N, Betems A, Bluteau O, et al.
Stem Cell Reports
. 2014 Dec;
3(6):1085-102.
PMID: 25458892
Hematopoietic stem cells (HSCs) are characterized by the capacity for self-renewal and the ability to reconstitute the entire hematopoietic compartment. Thrombopoietin maintains adult HSCs in a quiescent state through the...
9.
Mokrani M, Klibi J, Bluteau D, Bismuth G, Mami-Chouaib F
J Immunol
. 2014 Jan;
192(5):2471-9.
PMID: 24477908
The interaction of integrin αE(CD103)β7, often expressed on tumor-infiltrating T lymphocytes, with its cognate ligand, the epithelial cell marker E-cadherin on tumor cells, plays a major role in antitumor CTL...
10.
Bluteau D, Balduini A, Balayn N, Currao M, Nurden P, Deswarte C, et al.
J Clin Invest
. 2014 Jan;
124(2):580-91.
PMID: 24430186
Point mutations in the 5' UTR of ankyrin repeat domain 26 (ANKRD26) are associated with familial thrombocytopenia 2 (THC2) and a predisposition to leukemia. Here, we identified underlying mechanisms of...